Status:
COMPLETED
Remifentanil and Stress Hormones Response
Lead Sponsor:
Catholic University of the Sacred Heart
Conditions:
Stress Response
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Perioperative adequate analgesia reduces neuroendocrine stress response and postoperative complications. Because opioids are the most effective parenteral drugs to control pain and stress response, in...
Detailed Description
Fifty Caucasian patients, aged 20-70 years, with American Society of Anesthesiologist physical status I-II, undergoing laparoscopic cholecystectomy were enrolled. Exclusion criteria were: patient refu...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologist physical status I-II
- Undergoing laparoscopic cholecystectomy
Exclusion
- patient refusal,
- thyroid disorders,
- diabetes mellitus,
- BMI \> 30,
- use of corticosteroids, benzodiazepines or antipsychotics drugs
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03378674
Start Date
January 1 2008
End Date
July 1 2012
Last Update
January 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic University of Sacred Heart
Rome, Italy, 00168